ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/06/2025
Voltar para busca
Dado oficial do USPTO
AMAG PHARMACEUTICALS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
AMAG PHARMACEUTICALS
ST13
US500000077980168Classe
5, 40
Pedido
77980168
Registro
3949095
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
91
Atualização mais recente
05/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40
Data de depósito
18/04/2007
Data de registro
19/04/2011
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/08/2021
Última transação
05/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
06/02/2008
Primeiro uso no comércio
06/02/2008
Código do desenho
4
Tipo de titular
16
Localização do titular
ZUG, CH
Examinador
LOVELACE, JAMES
Unidade examinadora
M80
Localização atual
TMO LAW OFFICE 117
Titulares e representantes
Titulares
COVIS PHARMA GMBH
AMAG PHARMACEUTICALS, INC.
AMAG PHARMACEUTICALS, INC.
AMAG PHARMACEUTICALS, INC.
Advanced Magnetics, Inc.
Representantes
Laura K. Pitts Buchanan Ingersoll & Rooney PC
Classificação técnica
Classes Nice
Classe 5Classe 40
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical preparations for the treatment of anemia and pharmaceuticalsmedical imaging agents to aid in the diagnosis of cancer and cardiovascular disease
Classe 40
manufacturing services for others in the field of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
91 publicações encontradas
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/04/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
23/06/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
19/05/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/02/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
02/08/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/08/2021
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
02/08/2021
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
02/08/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/08/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
19/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/02/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
17/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/02/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17/02/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/02/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
19/04/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/06/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/06/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/06/2017
E815
TEAS SECTION 8 & 15 RECEIVED
19/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
19/04/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/03/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
15/03/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14/03/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/03/2011
ALIE
ASSIGNED TO LIE
11/03/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2011
MPMK
NOTICE OF PSEUDO MARK MAILED
19/08/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/08/2010
GNRT
NON-FINAL ACTION E-MAILED
18/08/2010
CNRT
SU - NON-FINAL ACTION - WRITTEN
18/08/2010
SUPC
STATEMENT OF USE PROCESSING COMPLETE
18/08/2010
DPCC
DIVISIONAL PROCESSING COMPLETE
18/08/2010
IUAF
USE AMENDMENT FILED
11/08/2010
DRRR
DIVISIONAL REQUEST RECEIVED
11/08/2010
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/08/2010
EISU
TEAS STATEMENT OF USE RECEIVED
11/08/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2010
EX4G
SOU EXTENSION 4 GRANTED
07/06/2010
EXT4
SOU EXTENSION 4 FILED
02/06/2010
EEXT
SOU TEAS EXTENSION RECEIVED
02/06/2010
EX3G
SOU EXTENSION 3 GRANTED
07/12/2009
EXT3
SOU EXTENSION 3 FILED
02/12/2009
EEXT
SOU TEAS EXTENSION RECEIVED
02/12/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/07/2009
PAPER RECEIVED
21/07/2009
EX2G
SOU EXTENSION 2 GRANTED
15/06/2009
EXT2
SOU EXTENSION 2 FILED
10/06/2009
EEXT
SOU TEAS EXTENSION RECEIVED
10/06/2009
EX1G
SOU EXTENSION 1 GRANTED
11/03/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/03/2009
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
02/02/2009
PETG
PETITION TO REVIVE-GRANTED
02/02/2009
PROA
TEAS PETITION TO REVIVE RECEIVED
02/02/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/01/2009
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/01/2009
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
26/01/2009
ABN6
ABANDONMENT - NO USE STATEMENT FILED
26/01/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/01/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/01/2009
EXT1
SOU EXTENSION 1 FILED
24/12/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
24/06/2008
PUBO
PUBLISHED FOR OPPOSITION
01/04/2008
NPUB
NOTICE OF PUBLICATION
12/03/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
23/02/2008
ALIE
ASSIGNED TO LIE
23/02/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/01/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
23/01/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
14/01/2008
GNSL
LETTER OF SUSPENSION E-MAILED
14/01/2008
CNSL
SUSPENSION LETTER WRITTEN
14/01/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
14/01/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/01/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
14/01/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/01/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/01/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/08/2007
GNRT
NON-FINAL ACTION E-MAILED
03/08/2007
CNRT
NON-FINAL ACTION WRITTEN
03/08/2007
DOCK
ASSIGNED TO EXAMINER
01/08/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
25/04/2007
NWAP
NEW APPLICATION ENTERED
24/04/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AMAG PHARMACEUTICALS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.